UNSPSC 51191934: Thiamine chloride hydrochloride

This classification denotes a b vitamin with the molecular formula C12H17N4OS.Cl. ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier M572600E5P, chemically known as thiazolium, 3-((4-amino-2-methyl-5-pyrimidinyl)methyl)-5-(2-hydroxyethyl)-4-methyl-, chloride, monohydrochloride, but more generally known as thiamine chloride hydrochloride, which bears US NIH Compound Identifier 1130.

European Medicines Agency schedules thiamine chloride hydrochloride or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10969MIG. Most nations, for tariff purposes, schedule thiamine chloride hydrochloride under HS 29362200. SMILES: CC1C(SC[N+]1CC2CNC(NC2N)C)CCO.CL.[CL-].

UNSPSC 51191934 Thiamine chloride hydrochloride, a Commodity code, represents pharmaceutical and chemical supply for state and local government operations, though recent solicitations tagged under this code span a broader range of chemical and pharmaceutical products than the code's nominal scope suggests. State and local governments buying under this code procure water-treatment chemicals, generic pharmaceuticals, and over-the-counter products for distribution across municipal utilities, state health facilities, and participating jurisdictions within cooperative purchasing alliances. Issuing bodies include municipal water authorities (such as the City of Meriden, Connecticut), state procurement offices administering multistate cooperative purchasing agreements, and participating state and local health-care and facility-operations agencies.

Activity under the code clusters in the Upper Midwest and Northeast, with recent examples including Connecticut and Minnesota. The City of Meriden issued an IFB (Solicitation B02715) for sodium bisulfite supply to its Water Pollution Control Facility, with bids due July 29, 2026, requiring General Liability and Auto Liability coverage of $1,000,000 to $2,000,000 and performance and payment bonds. The Minnesota Department of Administration's Office of State Procurement, administering the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), issued a Request for Proposal (S1070000015802) to establish multiple contracts for generic multi-source pharmaceuticals and over-the-counter products effective July 1, 2026, with proposals due March 26, 2026; the RFP requires cGMP and Drug Supply Chain Security Act compliance, $5,000,000 commercial general liability insurance, and pricing evaluated on competitiveness (75 percent weight) and administrative compliance metrics. Vendors must maintain relationships with authorized wholesalers and supply products through chargeback systems.